Moreover, our in vitro analysis further clarified that LAT1 suppression in CRC cells increased oxaliplatin sensitivity via suppression of oxaliplatin-induced p-mTOR and p-p70S6K. The gene discussed is MTOR; the disease is colorectal carcinoma.